Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Analgesic actions of N ‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

Open access
Maione, S, De Petrocellis, L, de Novellis, V, Moriello, A Schiano, Petrosino, S, Palazzo, E, Rossi, F Sca, Woodward, D F, Di Marzo, V·2007·British Journal of Pharmacology

Abstract

Background and purpose: N ‐arachidonoyl‐serotonin (AA‐5‐HT) is an inhibitor of fatty acid amide hydrolase (FAAH)‐catalysed hydrolysis of the endocannabinoid/ endovanilloid compound, anandamide (AEA). We investigated if AA‐5‐HT antagonizes the transient receptor potential vanilloid‐1 (TRPV1) channel and, as FAAH and TRPV1 are targets for analgesic compounds, if it exerts analgesia in rodent models of hyperalgesia. Experimental approach: AA‐5‐HT was tested in vitro , on HEK‐293 cells overexpressing the human or the rat recombinant TRPV1 receptor, and in vivo , in rats and mice treated with formalin and in rats with chronic constriction injury of the sciatic nerve. The levels of the endocannabinoids, AEA and 2‐arachidonoylglycerol, in supraspinal (periaqueductal grey, rostral ventromedial medulla), spinal or peripheral (skin) tissues were measured. Key results: AA‐5‐HT behaved as an antagonist at both rat and human TRPV1 receptors (IC 50 =37‐40 nM against 100 nM capsaicin). It exerted strong analgesic activity in all pain models used here. This activity was partly due to FAAH inhibition, elevation of AEA tissue levels and indirect activation of cannabinoid CB 1 receptors, as it was reversed by AM251, a CB 1 antagonist. AA‐5‐HT also appeared to act either via activation/desensitization of TRPV1, following elevation of AEA, or as a direct TRPV1 antagonist, as suggested by the fact that its effects were either reversed by capsazepine and 5′‐iodo‐resiniferatoxin, two TRPV1 antagonists, or mimicked by these compounds administered alone. Conclusions and implications: Possibly due to its dual activity as a FAAH inhibitor and TRPV1 antagonist, AA‐5‐HT was highly effective against both acute and chronic peripheral pain. British Journal of Pharmacology (2007) 150 , 766–781. doi: 10.1038/sj.bjp.0707145

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707145

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 196

Metadata

Authors
Maione, S., De Petrocellis, L., de Novellis, V, Moriello, A. S., Petrosino, S., Palazzo, E., Rossi, F. S., Woodward, D. F., & Di Marzo, V
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2007-03
Volume
150
Issue
6
Pages
766-781
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2092971703
Cited by
196
References
8
FWCI
12.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analgesic actions of N ‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0707145
The paper
Maione, S., De Petrocellis, L., de Novellis, V, Moriello, A. S., Petrosino, S., Palazzo, E., Rossi, F. S., Woodward, D. F., & Di Marzo, V. (2007). Analgesic actions of N ‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.